These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effectiveness of electroconvulsive therapy for drug-induced parkinsonism in the elderly. Sadananda SK; Holla B; Viswanath B; Narasimha A; Sebastian A; Math SB; Chandrashekar CR J ECT; 2013 Mar; 29(1):e6-7. PubMed ID: 23422531 [No Abstract] [Full Text] [Related]
5. The Parkinsonian syndrome and its dopamine correlates. Hoehn MM; Crowley TJ; Rutledge CO Adv Exp Med Biol; 1977; 90():243-54. PubMed ID: 930745 [TBL] [Abstract][Full Text] [Related]
6. Irreversible drug induced parkinsonism (two case reports). Sahoo RN; Mitra GC; Mohanty PC J Assoc Physicians India; 1975 Aug; 23(8):529-30. PubMed ID: 355 [No Abstract] [Full Text] [Related]
7. Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. Bashford G; Bradd P J Geriatr Psychiatry Neurol; 1996 Jul; 9(3):133-5. PubMed ID: 8873877 [TBL] [Abstract][Full Text] [Related]
8. Seborrheic dermatitis: a newly reported side effect of neuroleptics. Binder RL; Jonelis FJ J Clin Psychiatry; 1984 Mar; 45(3):125-6. PubMed ID: 6142036 [TBL] [Abstract][Full Text] [Related]
9. Taste sensitivity and the appearance of phenothiazine-tranquilizer induced extrapyramidal symptoms. Fischer R; Knopp W; Griffin F Arzneimittelforschung; 1965 Dec; 15(12):1379-82. PubMed ID: 5899813 [No Abstract] [Full Text] [Related]
10. Two cases of parkinsonism developing after industrial exposure to trifluperazine. Srikant G; Kantharaj L; Rao PR J Assoc Physicians India; 1986 Jun; 34(6):455. PubMed ID: 3771494 [No Abstract] [Full Text] [Related]
11. Relationship of individual tolerance, behavior and phenothiazine produced extrapyramidal system disturbance. Simpson GM; Kunz-Bartholini E Dis Nerv Syst; 1968 Apr; 29(4):269-74. PubMed ID: 5652493 [No Abstract] [Full Text] [Related]
15. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics. Moleman P; Schmitz PJ; Ladee GA J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250 [TBL] [Abstract][Full Text] [Related]
16. The clinical association of tardive dyskinesia and drug-induced parkinsonism. Wolf ME; Chevesich J; Lehrer E; Mosnaim AD Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032 [No Abstract] [Full Text] [Related]
17. Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy. Demars JP J Nerv Ment Dis; 1966 Jul; 143(1):73-9. PubMed ID: 5334365 [No Abstract] [Full Text] [Related]
18. [Pathogenesis and treatment of manganese induced Parkinsonism]. Ryzhkova MN; Tarasova LA Gig Tr Prof Zabol; 1975 Nov; (11):31-4. PubMed ID: 1205189 [No Abstract] [Full Text] [Related]
19. [Clozapine in the treatment of mental manifestations of Parkinson disease]. Diederich N; Keipes M; Graas M; Metz H Rev Neurol (Paris); 1995 Apr; 151(4):251-7. PubMed ID: 7481376 [TBL] [Abstract][Full Text] [Related]
20. Parkinsonism during cyclosporine treatment. Wasserstein PH; Honig LS Bone Marrow Transplant; 1996 Sep; 18(3):649-50. PubMed ID: 8879634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]